CA1065851A - Procede pour l'obtention du compose 17-alpha-ethinyl (5 alpha) 2-androstene 17 beta-ol a l'etat pur et applications therapeutiques du compose obtenu par ce procede - Google Patents

Procede pour l'obtention du compose 17-alpha-ethinyl (5 alpha) 2-androstene 17 beta-ol a l'etat pur et applications therapeutiques du compose obtenu par ce procede

Info

Publication number
CA1065851A
CA1065851A CA218,033A CA218033A CA1065851A CA 1065851 A CA1065851 A CA 1065851A CA 218033 A CA218033 A CA 218033A CA 1065851 A CA1065851 A CA 1065851A
Authority
CA
Canada
Prior art keywords
alpha
androstene
beta
ethinyl
keto
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA218,033A
Other languages
English (en)
French (fr)
Inventor
Nicolas Gueritee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Theramex SAM
Original Assignee
Laboratoire Theramex SAM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Theramex SAM filed Critical Laboratoire Theramex SAM
Application granted granted Critical
Publication of CA1065851A publication Critical patent/CA1065851A/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J11/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA218,033A 1974-01-17 1975-01-16 Procede pour l'obtention du compose 17-alpha-ethinyl (5 alpha) 2-androstene 17 beta-ol a l'etat pur et applications therapeutiques du compose obtenu par ce procede Expired CA1065851A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2211/74A GB1492746A (en) 1974-01-17 1974-01-17 Androstane derivatives and compositions containing them

Publications (1)

Publication Number Publication Date
CA1065851A true CA1065851A (fr) 1979-11-06

Family

ID=9735557

Family Applications (1)

Application Number Title Priority Date Filing Date
CA218,033A Expired CA1065851A (fr) 1974-01-17 1975-01-16 Procede pour l'obtention du compose 17-alpha-ethinyl (5 alpha) 2-androstene 17 beta-ol a l'etat pur et applications therapeutiques du compose obtenu par ce procede

Country Status (19)

Country Link
JP (1) JPS576439B2 (xx)
AR (1) AR203672A1 (xx)
AU (1) AU521392B2 (xx)
BE (1) BE823594A (xx)
BR (1) BR7500346A (xx)
CA (1) CA1065851A (xx)
CH (1) CH606091A5 (xx)
DE (1) DE2501091A1 (xx)
DK (1) DK135538B (xx)
ES (1) ES433677A1 (xx)
FR (1) FR2258185B1 (xx)
GB (1) GB1492746A (xx)
IE (1) IE40477B1 (xx)
IT (1) IT1044268B (xx)
LU (1) LU71662A1 (xx)
NL (1) NL183402C (xx)
PH (1) PH15366A (xx)
SE (1) SE7500479L (xx)
ZA (1) ZA75254B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE19781T1 (de) * 1981-06-02 1986-05-15 Theramex Androstenen enthaltenden pharmazeutische zusammensetzungen.
JPS60173248A (ja) * 1984-02-16 1985-09-06 三晃金属工業株式会社 嵌合外囲体
WO1986001208A1 (en) * 1984-08-17 1986-02-27 Sri International Stereoisometrically pure 17-alpha-ethynyl-estra-2-en-17beta-ol and esters thereof
US5116830A (en) * 1984-08-17 1992-05-26 Sri International Stereoisomerically pure 17α-ethynyl-estra-2-en-17β-ol and the 17β esters thereof, methods of preparation and uses
ATE40139T1 (de) * 1985-04-29 1989-02-15 Theramex Verfahren zur herstellung von reinen androst-2enderivaten.
FR2598083B1 (fr) * 1986-05-05 1989-12-29 Theramex Laboratoire Nouvelles compositions pharmaceutiques a action antiprogesteronique et leur procede d'obtention
RU2652702C2 (ru) 2016-10-19 2018-04-28 Игорь Ву-Юнович Ван Субатмосферная система теплохолодоснабжения

Also Published As

Publication number Publication date
JPS576439B2 (xx) 1982-02-04
PH15366A (en) 1982-12-10
NL183402C (nl) 1988-10-17
FR2258185A1 (xx) 1975-08-18
GB1492746A (en) 1977-11-23
BE823594A (fr) 1975-04-16
LU71662A1 (xx) 1975-06-24
DE2501091A1 (de) 1975-07-24
ES433677A1 (es) 1976-11-16
AU7733575A (en) 1976-07-15
IE40477L (en) 1975-07-17
NL183402B (nl) 1988-05-16
DK135538C (xx) 1977-10-24
FR2258185B1 (xx) 1978-07-28
BR7500346A (pt) 1975-11-04
ZA75254B (en) 1976-01-28
CH606091A5 (xx) 1978-10-13
SE7500479L (xx) 1975-07-18
AR203672A1 (es) 1975-09-30
IT1044268B (it) 1980-03-20
DK690574A (xx) 1975-09-29
AU521392B2 (en) 1982-04-01
JPS50106952A (xx) 1975-08-22
DK135538B (da) 1977-05-16
IE40477B1 (en) 1979-06-06
NL7500608A (nl) 1975-07-21

Similar Documents

Publication Publication Date Title
Aoki et al. Is there a local feedback from the seminiferous tubules affecting activity of the Leydig cells?
US3800038A (en) Uterine administraton of eutectic solid solutions of steroid hormones in a steroidal lipid carrier
CN106083969B (zh) 合成胆汁酸组合物、方法和制剂
CLAESSON et al. The Formation Mechanism of Oestrogenic Hormones: The Presence of an Oestrogen‐Precursor in the Rabbit Ovary 1
CA1065851A (fr) Procede pour l'obtention du compose 17-alpha-ethinyl (5 alpha) 2-androstene 17 beta-ol a l'etat pur et applications therapeutiques du compose obtenu par ce procede
AU2008323198B2 (en) C-19 steroids for cosmetic and further uses
JP2003510336A (ja) 虚血性損傷においてのエストロゲンのエナンチオマーを用いる細胞保護の方法
JP2002518514A (ja) テストステロン誘導体
EP2949361B1 (en) C-19 steroids for treating cellulite
Ahluwalia et al. Effects of exogenous hormones on the male reproductive organs of vitamin A-deficient rats
EP1294382B1 (en) 7-hydroxyepiandrosterone having neuroprotective activity
Dalkin et al. Gonadal steroids effect similar regulation of gonadotrophin subunit mRNA expression in both male and female rats
JPS61289096A (ja) ジヒドロテストステロン・ヘプタノエ−ト、その合成および使用方法
MARKS et al. Effect of amphenone upon steroidogenesis in the adrenal cortex of the golden hamster
Somade et al. Effect of edible camphor administrations on levels of steroid and thyroid hormones in male wistar rats
RAVID et al. Androstanediol sulphates in peripheral blood of immature rats and some of their biological effects
FR2417M (xx)
Chung et al. Testicular lipids in mice with testicular feminization
CA1140111A (fr) PROCEDE DE PREPARATION D'UN NOUVEAU DERIVE DU (20S) 3.alpha.- /(AMINO-ACETYL)AMINO/ 5.alpha.-PREGNAN-20-OL ET DE SES SELS
EP0240717A2 (en) Prevention of mammary carcinoma
DE60210268T2 (de) Verfahren zur herstellung von 7alpha,11beta-dimethyl-17beta-hydroxyestra-4, 14-dien-3-one, dessen 17-ester und pharmazeutische zubereitungen die sie enthalten
RU2066184C1 (ru) Средство для лечения себореи и угревой сыпи
Ota et al. Inhibition of testicular androgenesis by urinary gonadotropin-inhibiting substances in rats
Shore Metabolism of Testosterone and Progesterone by Neural Tissue
CH616690A5 (en) Process for the preparation of a new alkoxylated steroid